TXMD Stock Summary and Trading Ideas (Therapeuticsmd | NASDAQ:TXMD)

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Therapeuticsmd trades on the NASDAQ stock market under the symbol TXMD.

As of June 18, 2026, TXMD stock price declined to $1.95 with 67,101 million shares trading.

TXMD has a beta of 0.68, meaning it tends to be less sensitive to market movements. TXMD has a correlation of 0.02 to the broad based SPY ETF.

TXMD has a market cap of $22.57 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, TXMD traded as high as $4.35 and as low as $.70.

The top ETF exchange traded funds that TXMD belongs to (by Net Assets): VTI, VXF, DFAC, DFSU, DCOR.

TXMD has outperformed the market in the last year with a return of +74.1%, while the SPY ETF gained +26.2%. However, in the most recent history, TXMD shares have underperformed the stock market with its stock returning -12.6% in the last 3 month period and -1.0% for the last 2 week period, while SPY has returned +11.6% and -1.0%, respectively.

TXMD support price is $2.15 and resistance is $2.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TXMD shares will trade within this expected range on the day.